Francesca De Santis

454 total citations
24 papers, 342 citations indexed

About

Francesca De Santis is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Francesca De Santis has authored 24 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Immunology. Recurrent topics in Francesca De Santis's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (5 papers) and Immunotherapy and Immune Responses (5 papers). Francesca De Santis is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (5 papers) and Immunotherapy and Immune Responses (5 papers). Francesca De Santis collaborates with scholars based in Italy, Spain and United States. Francesca De Santis's co-authors include Pier Giuseppe Pelicci, Raffaella Villa, Massimo Di Nicola, Arantxa Gutiérrez, Luciano Di Croce, Saverio Minucci, Florencio Varas, Marcus Buschbeck, Massimo Corsaro and Yvan Torrente and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Francesca De Santis

22 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca De Santis Italy 10 262 60 53 36 30 24 342
Akira Tanimura Japan 14 222 0.8× 61 1.0× 100 1.9× 73 2.0× 11 0.4× 28 413
Kateřina Čapková United States 10 152 0.6× 92 1.5× 27 0.5× 20 0.6× 11 0.4× 10 366
Hui Si Kwok United States 10 200 0.8× 39 0.7× 22 0.4× 25 0.7× 36 1.2× 12 258
Xiangpeng Sheng China 5 157 0.6× 33 0.6× 55 1.0× 17 0.5× 13 0.4× 8 273
Elisabeth J. Shaw United Kingdom 8 138 0.5× 74 1.2× 15 0.3× 25 0.7× 27 0.9× 16 289
Winnie Tan Australia 11 357 1.4× 75 1.3× 17 0.3× 22 0.6× 51 1.7× 16 443
Lynn Lehmann United States 8 317 1.2× 44 0.7× 13 0.2× 20 0.6× 47 1.6× 9 406
Elizabeta A. Rojas Spain 11 288 1.1× 78 1.3× 111 2.1× 22 0.6× 25 0.8× 19 395
Charu Mehta United States 12 209 0.8× 22 0.4× 60 1.1× 72 2.0× 39 1.3× 18 321
Mitsuhiko Osaka Japan 9 263 1.0× 64 1.1× 60 1.1× 11 0.3× 23 0.8× 15 355

Countries citing papers authored by Francesca De Santis

Since Specialization
Citations

This map shows the geographic impact of Francesca De Santis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca De Santis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca De Santis more than expected).

Fields of papers citing papers by Francesca De Santis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca De Santis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca De Santis. The network helps show where Francesca De Santis may publish in the future.

Co-authorship network of co-authors of Francesca De Santis

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca De Santis. A scholar is included among the top collaborators of Francesca De Santis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca De Santis. Francesca De Santis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santis, Francesca De, Silvia Brich, Andrea Vingiani, et al.. (2025). 43P Immunosuppressive microenvironment can be reverted by neoadjuvant chemotherapy in TNBC. ESMO Open. 10. 104202–104202.
2.
Rivoltini, Licia, Chiara Camisaschi, Giovanni Fucà, et al.. (2024). Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade. Scientific Reports. 14(1). 3379–3379. 6 indexed citations
3.
Santis, Francesca De, Sandra Romero‐Córdoba, Lorenzo Castagnoli, et al.. (2022). BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer. Cellular Oncology. 45(2). 257–274. 15 indexed citations
4.
Mainini, Francesco, Francesca De Santis, Giovanni Fucà, et al.. (2021). Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer. Cancers. 13(15). 3765–3765. 8 indexed citations
5.
Santis, Francesca De, Giovanni Fucà, Dirk Schadendorf, et al.. (2021). Anticancer innovative therapy congress: Highlights from the 10th anniversary edition. Cytokine & Growth Factor Reviews. 59. 1–8. 3 indexed citations
6.
Ambrosini, Margherita, Giovanni Fucà, Matteo Duca, et al.. (2021). Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?. Critical Reviews in Oncology/Hematology. 169. 103532–103532. 4 indexed citations
7.
Verderio, Paolo, Vera Cappelletti, Francesca De Santis, et al.. (2021). A combination of extracellular matrix‐ and interferon‐associated signatures identifies high‐grade breast cancers with poor prognosis. Molecular Oncology. 15(5). 1345–1357. 9 indexed citations
8.
Castagnoli, Lorenzo, Francesca De Santis, Claudio Vernieri, et al.. (2020). Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure. Cells. 9(3). 555–555. 22 indexed citations
9.
Mazzini, Stefania, Raimundo Gargallo, Loana Musso, et al.. (2019). Stabilization of c-KIT G-Quadruplex DNA Structures by the RNA Polymerase I Inhibitors BMH-21 and BA-41. International Journal of Molecular Sciences. 20(19). 4927–4927. 24 indexed citations
10.
Santis, Francesca De, Michele Del Vecchio, Lorenzo Castagnoli, et al.. (2018). Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting. Cytokine & Growth Factor Reviews. 44. 1–10. 1 indexed citations
11.
12.
D’Avila, Francesca, Mirella Meregalli, Sara Lupoli, et al.. (2016). Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy. Journal of Muscle Research and Cell Motility. 37(3). 101–115. 22 indexed citations
13.
Dama, Elisa, Micol Tillhon, Giovanni Bertalot, et al.. (2016). Sensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase (ALK) alterations in patients with non-small cell lung cancer. Oncotarget. 7(24). 37160–37176. 5 indexed citations
14.
Colombo, Federico, Elena Trombetta, Marco Maggioni, et al.. (2014). Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells. PLoS ONE. 9(12). e114787–e114787. 39 indexed citations
15.
Iotti, Giorgio Antonio, Elena Longobardi, Leila Dardaei, et al.. (2011). Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability. Proceedings of the National Academy of Sciences. 108(29). E314–22. 32 indexed citations
16.
Perilli, Mariagrazia, María M. Tavío, Domenico Setacci, et al.. (2007). In VitroSelection and Characterization of Mutants in TEM-1-ProducingEscherichia coliby Ceftazidime and Ceftibuten. Journal of Chemotherapy. 19(2). 123–126. 3 indexed citations
17.
Villa, Raffaella, Lluís Morey, Veronica A. Raker, et al.. (2006). The methyl-CpG binding protein MBD1 is required for PML-RARα function. Proceedings of the National Academy of Sciences. 103(5). 1400–1405. 79 indexed citations
18.
Perilli, Mariagrazia, Bernardetta Segatore, Francesca De Santis, et al.. (2004). Overexpression system and biochemical profile of CTX-M-3 extended-spectrum β-lactamase expressed inEscherichia coli. FEMS Microbiology Letters. 241(2). 229–232. 2 indexed citations
19.
Villa, Raffaella, Francesca De Santis, Arantxa Gutiérrez, et al.. (2004). Epigenetic gene silencing in acute promyelocytic leukemia. Biochemical Pharmacology. 68(6). 1247–1254. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Tanimura Breakdown of academic impact, for papers by Kateřina Čapková Breakdown of academic impact, for papers by Hui Si Kwok Breakdown of academic impact, for papers by Xiangpeng Sheng Breakdown of academic impact, for papers by Elisabeth J. Shaw Breakdown of academic impact, for papers by Winnie Tan Breakdown of academic impact, for papers by Lynn Lehmann Breakdown of academic impact, for papers by Elizabeta A. Rojas Breakdown of academic impact, for papers by Charu Mehta Breakdown of academic impact, for papers by Mitsuhiko Osaka
Rankless by CCL
2026